Cargando…
The V(2) receptor antagonist tolvaptan counteracts proliferation and invasivity in human cancer cells
PURPOSE: Hyponatremia, the most frequent electrolyte alteration in clinical practice, has been associated with a worse prognosis in cancer patients. On the other hand, a better outcome has been related to serum sodium normalization. In vitro studies have shown that low extracellular sodium promotes...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360171/ https://www.ncbi.nlm.nih.gov/pubmed/35604542 http://dx.doi.org/10.1007/s40618-022-01807-5 |